Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-3.53%)
Close on Nov 12, 2026Market cap $5.67MP/E –Yield –
Tempest Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tempest Therapeutics's enterprise value was $5.56M on Nov 11, 2026, against $6.69M a year earlier. Over the last 5 years it ranged from -$20.72M to $62.02M, with a median of $5.56M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.56M | +6.4% |
| 2025 | Dec 31, 2025 | $5.23M | -32.6% |
| 2024 | Dec 31, 2024 | $7.76M | -87.5% |
| 2023 | Dec 29, 2023 | $62.02M | – |
| 2022 | Dec 30, 2022 | -$19.23M | – |
| 2021 | Dec 31, 2021 | -$8.32M | -101.5% |
| 2020 | Dec 31, 2020 | $566.97M | -56.9% |
| 2019 | Dec 31, 2019 | $1.32B | +3270.3% |
| 2018 | Dec 31, 2018 | $39.05M | -73.8% |
| 2017 | Dec 29, 2017 | $149.23M | +30.7% |
| 2016 | Dec 30, 2016 | $114.14M | -89.2% |
| 2015 | Dec 31, 2015 | $1.06B | -77.3% |
| 2014 | Dec 31, 2014 | $4.66B | +614.2% |
| 2013 | Dec 31, 2013 | $652.62M | +50.4% |
| 2012 | Dec 31, 2012 | $433.91M | – |
See a number that looks wrong?